Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Effect of Sildenafil on Exercise Tolerance in Lung Disease
NCT01382368Phase 4Unknown
- Sponsor
- Rabin Medical Center
- Start
- Sep 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ASP-001 in chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) (2 arms), sponsored by Rabin Medical Center. Primary endpoints: Peak Oxygen Consumption, 6 Minute Walk Test and 1 more. Status: unknown.
02
Drugs
ASP-001
03
Conditions
chronic obstructive pulmonary disease (COPD)idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT01382368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01382368.